top of page
Search

Peregrine Pharmaceuticals - NEW EBOLA Antiviral Therapy

_
Oct 17, 2014
1 min read

Peregrine Pharmaceuticals of Tustin , California , USA - is publishing very promising DATA on Phosphatidylserine-targeting monoclonal Antibody- Bravituximab for treatment of EBOLA- Viral Hemorrhagic Fever. It has already been used SAFELY in oncologic therapy in 600 patients - Worldwide

 
 
 

Recent Posts

See All
Scombroid Ichthyotoxicosis

https://mail-attachment.googleusercontent.com/attachment/u/0/?ui=2&ik=44d4567a35&attid=0.1&permmsgid=msg-f:1847695440674288165&th=19a45536ba7ff225&view=att&zw&disp=safe&saddbat=ANGjdJ8uxibP39cejvI5-XG

 
 
 

Comments





bottom of page